The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
PLx Pharma Inc. | COM | 72942A107 | 196 | 58,567 | SH | SOLE | 58,567 | 0 | 0 | ||
GENPREX INC | COM | 372446104 | 868 | 184,797 | SH | SOLE | 184,797 | 0 | 0 | ||
Synlogic Inc. | COM | 87166L100 | 975 | 103,949 | SH | SOLE | 103,949 | 0 | 0 | ||
Nanthealth Inc | COM | 630104107 | 80 | 26,464 | SH | SOLE | 26,464 | 0 | 0 | ||
SVRA | COM | 805111101 | 1,826 | 198,558 | SH | SOLE | 198,558 | 0 | 0 |